{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/sites\/default\/files\/js\/js_itu2PgFdrjV-docKmLK8Jn5oXe_05RgvQh73eOhI_mE.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js?nzmkf1\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js?nzmkf1\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/d282kpwvnogo5m.cloudfront.net\/sites\/default\/files\/js\/js_I8yX6RYPZb7AtMcDUA3QKDZqVkvEn35ED11_1i7vVpc.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\n(function(i,s,o,g,r,a,m){i[\u0022GoogleAnalyticsObject\u0022]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,\u0022script\u0022,\u0022\/\/www.google-analytics.com\/analytics.js\u0022,\u0022ga\u0022);ga(\u0022create\u0022, \u0022UA-15605596-27\u0022, {\u0022cookieDomain\u0022:\u0022auto\u0022});ga(\u0022set\u0022, \u0022page\u0022, location.pathname + location.search + location.hash);ga(\u0022send\u0022, \u0022pageview\u0022);ga(\u0027create\u0027, \u0027UA-189672-26\u0027, \u0027auto\u0027, {\u0027name\u0027: \u0027hwTracker\u0027});\r\nga(\u0027hwTracker.send\u0027, \u0027pageview\u0027);\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022spmdc;9\\\/2\\\/15\u0022},{\u0022requested\u0022:\u0022long\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022spmdc;9\\\/2\\\/15\u0022}],\u0022ac\u0022:{\u0022spmdc;9\\\/2\\\/15\u0022:{\u0022access\u0022:{\u0022reprint\u0022:true,\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022spmdc;9\\\/2\\\/15\u0022,\u0022atom_uri\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022spmdc\u0022}}},\u0022googleanalytics\u0022:{\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackUrlFragments\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022sites\\\/all\\\/libraries\\\/cluetip\\\/jquery.cluetip.js\u0022:1,\u0022sites\\\/all\\\/libraries\\\/cluetip\\\/lib\\\/jquery.hoverIntent.js\u0022:1,\u0022sites\\\/all\\\/libraries\\\/cluetip\\\/lib\\\/jquery.bgiframe.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u00220\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/d282kpwvnogo5m.cloudfront.net\/sites\/default\/files\/advagg_css\/css__ce2QY63WIanKyr8eSq7eavr1XQRRmFD6ZSmwpyJi8lM__zXwFqpqmxrZOXXcd_TpBQpjuELbmIP9wBR5UuTDWAO4__YJWWMMdfCJuAFm5cUEp88OsodhO3ZA-2lzRfoBsSlk4.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-sageoa-tab-art\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 id=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2\u003ESummary\u003C\/h2\u003E\n            \u003Cp id=\u0022p-1\u0022\u003EResults of the Indian Polycap Study [TIPS; \u003Ca class=\u0022external-ref external-ref-type-clintrialgov\u0022 href=\u0022\/lookup\/external-ref?link_type=CLINTRIALGOV\u0026amp;access_num=NCT00443794\u0026amp;atom=%2Fspmdc%2F9%2F2%2F15.atom\u0022\u003ENCT00443794\u003C\/a\u003E] indicate that it may be possible for individuals who have average risk factors for cardiovascular disease to significantly reduce their risk for heart disease and stroke through the use of a single pill\u2014the Polycap\u2122\u2014which combines low doses of thiazide (12.5 mg), atenolol (50 mg), ramipril (5 mg), simvastatin (20 mg), and aspirin (100 mg).\u003C\/p\u003E\n         \u003C\/div\u003E\u003Cul class=\u0022kwd-group\u0022\u003E\u003Cli class=\u0022kwd\u0022\u003EPrevention \u0026amp; Screening Clinical Trials\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-2\u0022\u003EResults of the Indian Polycap Study (TIPS; \u003Ca class=\u0022external-ref external-ref-type-clintrialgov\u0022 href=\u0022\/lookup\/external-ref?link_type=CLINTRIALGOV\u0026amp;access_num=NCT00443794\u0026amp;atom=%2Fspmdc%2F9%2F2%2F15.atom\u0022\u003ENCT00443794\u003C\/a\u003E) indicate that it may be possible for individuals who have average risk factors for cardiovascular disease to significantly reduce their risk for heart disease and stroke through the use of a single pill\u2014the Polycap\u2122\u2014which combines low doses of thiazide (12.5 mg), atenolol (50 mg), ramipril (5 mg), simvastatin (20 mg), and aspirin (100 mg). The results of TIPS were presented by the joint principal investigator of the study, Salim Yusuf, PhD, McMaster University, Hamilton, ON, Canada, at the American College of Cardiology 58\u003Csup\u003Eth\u003C\/sup\u003E Annual Scientific Session in Orlando, FL.\u003C\/p\u003E\u003Cp id=\u0022p-3\u0022\u003EThe primary objective of TIPS was to determine whether the Polycap\u2122 is equivalent to its individual components in reducing blood pressure (BP) and heart rate (HR), modifying lipids, and suppressing urine thromboxane B2 and whether it has a similar adverse event profile. The secondary objective of TIPS was to determine whether the Polycap\u2122 is superior in reducing BP compared with its components.\u003C\/p\u003E\u003Cp id=\u0022p-4\u0022\u003EThe study population comprised 2053 subjects aged 45 to 80 years (mean age 54 years; 44% women) without cardiovascular disease but with at least 1 risk factor. One-third (33.9%) of the subjects had diabetes, mean baseline BP was 134\/85 mm Hg, and mean cholesterol was 180 mg\/dl (HDL 44 mg\/dL and LDL 117 mg\/dL).\u003C\/p\u003E\u003Cp id=\u0022p-5\u0022\u003ESubjects were randomly assigned to receive either the Polycap\u2122(n=412) or 1 of 8 other formulations (n\u2248200 each) for 12 weeks. The 8 other formulations, which used the same doses of agents as Polycap\u2122, were: aspirin alone, thiazide alone, thiazide + either ramipril or atenolol or both, thiazide + ramipril + atenolol + aspirin, ramipril + atenenol, and simvastatin alone.\u003C\/p\u003E\u003Cp id=\u0022p-6\u0022\u003EIn the Polycap group, BP reductions (7.4 mm Hg systolic and 5.6 mm Hg diastolic) were comparable with those that were seen in the group that received 3 BP medications (6.9 mm Hg systolic and 5.0 mm Hg diastolic). Aspirin did not interfere with the BP-lowering effects of the Polycap\u2122.\u003C\/p\u003E\u003Cp id=\u0022p-7\u0022\u003ELDL reductions in the group that was randomized to Polycap\u2122 (0.70 mmol\/L [23.3%]), however, were significantly lower than those that were seen in the group that received simvastatin alone (0.83 mmol\/L [27.7%]; p\u0026lt;0.04), leading the investigators to speculate that the 40 mg dose should be tried instead of the 20 mg dose of simvastatin in order to enhance the benefits. Reductions in LDL for both groups of individuals who received the polycap, however, were significantly (p\u0026lt;0.0001) better than for subjects who did not receive simvastatin.\u003C\/p\u003E\u003Cp id=\u0022p-8\u0022\u003EThe reductions in HR with Polycap\u2122 (7.0 beats\/min) and other arms using atenolol (7.0 beats\/min) were similar, and both were significantly greater than those in subjects who did not receive atenolol (p\u0026lt;0.001). The reduction in thromboxane B2 that was seen with Polycap\u2122 (\u2212322.3) was similar to that seen with aspirin alone (\u2212388.0) or the combination of thiazide, atenolol, and ramipril + aspirin (\u2212389.3; all p\u0026lt;0.001 vs baseline).\u003C\/p\u003E\u003Cp id=\u0022p-9\u0022\u003EPolycap\u2122 was well tolerated, and there was no evidence of increasing rates of adverse effects or discontinuation of study drugs with increasing numbers of active components in the pill.\u003C\/p\u003E\u003Cp id=\u0022p-10\u0022\u003EBased on the results of this study, the investigators estimate that in individuals who are at average risk of cardiovascular disease, the use of Polycap\u2122 could potentially result in a 62% reduction in the relative risk for coronary heart disease and a 48% reduction in the relative risk for stroke. However, they emphasized the need for large, prospective randomized trials to evaluate this hypothesis.\u003C\/p\u003E\u003Cp id=\u0022p-11\u0022\u003EThe study was sponsored by Cadila Pharmaceuticals, India, which played no role in data collection, analysis, or interpretation.\u003C\/p\u003E\u003Cp id=\u0022p-12\u0022\u003EResults of the TIPS study were simultaneously published in \u003Cem\u003EThe Lancet\u003C\/em\u003E (Online Publication, 30 March 2009).\u003C\/p\u003E\u003Cul class=\u0022copyright-statement\u0022\u003E\u003Cli class=\u0022fn\u0022 id=\u0022copyright-statement-1\u0022\u003E\u00a9 2009 MD Conference Express\u003C\/li\u003E\u003C\/ul\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan id=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Ca href=\u0022http:\/\/mdc.sagepub.com\/content\/9\/2\/15.abstract\u0022 class=\u0022hw-link hw-link-article-abstract\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView Summary\u003C\/a\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/mdc.sagepub.com\/sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js?nzmkf1\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}